HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 129 filers reported holding HERON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,238,000 | -22.6% | 216,477 | +23.6% | 0.00% | 0.0% |
| Q4 2021 | $1,599,000 | -15.8% | 175,178 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $1,900,000 | -23.6% | 177,772 | +10.9% | 0.00% | 0.0% |
| Q2 2021 | $2,488,000 | +17.5% | 160,332 | +22.7% | 0.00% | 0.0% |
| Q1 2021 | $2,118,000 | +8.6% | 130,689 | +41.9% | 0.00% | 0.0% |
| Q4 2020 | $1,950,000 | +80.9% | 92,115 | +26.6% | 0.00% | 0.0% |
| Q3 2020 | $1,078,000 | +0.1% | 72,746 | -0.7% | 0.00% | 0.0% |
| Q2 2020 | $1,077,000 | +34.1% | 73,245 | +7.1% | 0.00% | 0.0% |
| Q1 2020 | $803,000 | -70.0% | 68,411 | -40.0% | 0.00% | -50.0% |
| Q4 2019 | $2,678,000 | +49.1% | 113,960 | +17.4% | 0.00% | +100.0% |
| Q3 2019 | $1,796,000 | +66.9% | 97,097 | +67.8% | 0.00% | 0.0% |
| Q2 2019 | $1,076,000 | +8.2% | 57,874 | +42.2% | 0.00% | 0.0% |
| Q1 2019 | $994,000 | +2.2% | 40,688 | +8.5% | 0.00% | 0.0% |
| Q4 2018 | $973,000 | -56.8% | 37,512 | -47.3% | 0.00% | -50.0% |
| Q3 2018 | $2,252,000 | -45.5% | 71,155 | -33.1% | 0.00% | -50.0% |
| Q2 2018 | $4,135,000 | +33.2% | 106,435 | -5.4% | 0.00% | +33.3% |
| Q1 2018 | $3,105,000 | +207.1% | 112,482 | +101.4% | 0.00% | +200.0% |
| Q4 2017 | $1,011,000 | +38.9% | 55,839 | +23.8% | 0.00% | 0.0% |
| Q3 2017 | $728,000 | +55.2% | 45,090 | +33.1% | 0.00% | 0.0% |
| Q2 2017 | $469,000 | -5.6% | 33,872 | +2.2% | 0.00% | 0.0% |
| Q1 2017 | $497,000 | +114.2% | 33,139 | +86.8% | 0.00% | – |
| Q4 2016 | $232,000 | -35.4% | 17,745 | -14.9% | 0.00% | -100.0% |
| Q3 2016 | $359,000 | +68.5% | 20,847 | +76.4% | 0.00% | – |
| Q2 2016 | $213,000 | -84.0% | 11,818 | -76.3% | 0.00% | -100.0% |
| Q4 2015 | $1,332,000 | +115.2% | 49,894 | +96.6% | 0.00% | +100.0% |
| Q3 2015 | $619,000 | +109.1% | 25,377 | +166.8% | 0.00% | 0.0% |
| Q2 2015 | $296,000 | – | 9,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |